The Board of Directors at Tata Chemicals has approved the unaudited consolidated and audited standalone financial results for Q3 2026 and the nine months ending December 31, 2025. The meeting, held on February 2, 2026, concluded at 4:15 p.m. (IST). Results are available on the company website.
Financial Results Approved
Tata Chemicals’ Board of Directors has approved the unaudited consolidated and audited standalone financial results for the third quarter of fiscal year 2026 (Q3 2026) which ended on December 31, 2025. The decision was made at the board meeting held on Monday, February 2, 2026.
Key Meeting Details
The board meeting commenced at 2:00 p.m. (IST) and concluded at 4:15 p.m. (IST) on February 2, 2026.
Auditor Review of Consolidated Results
The limited review report on the unaudited consolidated financial results for Q3 2026 indicates a review conducted in accordance with the Standard on Review Engagements (SRE) 2410. BSR & Co. LLP, Chartered Accountants, issued the report, emphasizing that the statement does not contain any material misstatement.
Consolidated Financial Highlights
Key figures from the consolidated financial results include:
- Revenue from operations: ₹3,550 crore for Q3 2026.
- Total Income: ₹3,588 crore for Q3 2026.
- (Loss)/profit before tax: (₹73) crore for Q3 2026.
- (Loss)/profit for the period: (₹69) crore for Q3 2026.
- Total comprehensive income for the period: ₹884 crore for Q3 2026.
- Earnings per share for continuing operations: (₹3.65) for Q3 2026.
Standalone Financial Highlights
Key figures from the standalone financial results include:
- Revenue from operations: ₹1,204 crore for Q3 2026.
- Total Income: ₹1,220 crore for Q3 2026.
- Profit before tax: ₹73 crore for Q3 2026.
- Profit for the period: ₹73 crore for Q3 2026.
- Total comprehensive income for the period: ₹860 crore for Q3 2026.
- Earnings per share for continuing operations: ₹2.87 for Q3 2026.
Segment Performance
The company’s revenue is divided between basic chemistry products and specialty products. In the consolidated results, basic chemistry products accounted for ₹2,887 crore, while specialty products accounted for ₹667 crore in Q3 2026.
Availability of Results
The full financial results are available on the company’s website: www.tatachemicals.com.
Source: BSE
